Journal article
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial
The journal of clinical psychiatry, Vol.73(7), pp.1016-1022
07/2012
DOI: 10.4088/jcp.11m07100
PMCID: PMC3746329
PMID: 22687548
Abstract
The true benefit of pharmacologic intervention to improve cognition in schizophrenia may not be evident without regular cognitive enrichment. Clinical trials assessing the neurocognitive effects of new medications may require engagement in cognitive remediation exercises to stimulate the benefit potential. However, the feasibility of large-scale multisite studies using cognitive remediation at clinical trials sites has not been established.
Details
- Title: Subtitle
- Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial
- Creators
- Richard S E Keefe - Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. richard.keefe@duke.eduSophia VinogradovAlice MedaliaPeter F BuckleyStanley N CaroffDeepak C D'SouzaPhillip D HarveyKaren A GrahamRobert M HamerDel D MillerStephen M MarderStephen J OlsonJayendra K PatelDawn VelliganTrina M WalkerAdam J HaimT Scott Stroup
- Resource Type
- Journal article
- Publication Details
- The journal of clinical psychiatry, Vol.73(7), pp.1016-1022
- DOI
- 10.4088/jcp.11m07100
- PMID
- 22687548
- PMCID
- PMC3746329
- NLM abbreviation
- J Clin Psychiatry
- ISSN
- 0160-6689
- eISSN
- 1555-2101
- Publisher
- United States
- Grant note
- N01MH90001 / NIMH NIH HHS N01 MH900001 / NIMH NIH HHS
- Language
- English
- Date published
- 07/2012
- Academic Unit
- Psychiatry
- Record Identifier
- 9984003935402771
Metrics
28 Record Views